Peter Radovich - 06 Mar 2026 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
PRESIDENT AND COO
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
06 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 16:05:19 UTC
Previous filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Radovich Peter PRESIDENT AND COO C/O MIRUM PHARMACEUTICALS, INC., 989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY /s/ Judit Ryvkin, Attorney-in-Fact 11 Mar 2026 0001650131

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Options Exercise +5,912 +29% $15.87* 26,567 06 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Options Exercise -5,912 -9.9% $0.000000* 54,088 06 Mar 2026 Common Stock 5,912 $15.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested.